177 related articles for article (PubMed ID: 35483434)
1. Relationship between metformin use and lactic acidosis in advanced chronic kidney disease: The REMIND-TMU study.
Chen CC; Ko Y; Chen CH; Hung YJ; Wei TE; Chang TH; Ke SS; Kuo KN; Chen C
Am J Med Sci; 2022 Nov; 364(5):575-582. PubMed ID: 35483434
[TBL] [Abstract][Full Text] [Related]
2. Retrospective analysis of lactic acidosis-related parameters upon and after metformin discontinuation in patients with diabetes and chronic kidney disease.
Sipahi S; Solak Y; Acikgoz SB; Genc AB; Yildirim M; Yilmaz U; Nalbant A; Tamer A
Int Urol Nephrol; 2016 Aug; 48(8):1305-1312. PubMed ID: 27102431
[TBL] [Abstract][Full Text] [Related]
3. Association of Metformin Use With Risk of Lactic Acidosis Across the Range of Kidney Function: A Community-Based Cohort Study.
Lazarus B; Wu A; Shin JI; Sang Y; Alexander GC; Secora A; Inker LA; Coresh J; Chang AR; Grams ME
JAMA Intern Med; 2018 Jul; 178(7):903-910. PubMed ID: 29868840
[TBL] [Abstract][Full Text] [Related]
4. Metformin associated lactic acidosis (MALA): clinical profiling and management.
Moioli A; Maresca B; Manzione A; Napoletano AM; Coclite D; Pirozzi N; Punzo G; Menè P
J Nephrol; 2016 Dec; 29(6):783-789. PubMed ID: 26800971
[TBL] [Abstract][Full Text] [Related]
5. Metformin in patients with type 2 diabetes and kidney disease: a systematic review.
Inzucchi SE; Lipska KJ; Mayo H; Bailey CJ; McGuire DK
JAMA; 2014 Dec 24-31; 312(24):2668-75. PubMed ID: 25536258
[TBL] [Abstract][Full Text] [Related]
6. The Long-term Effects of Metformin on Patients With Type 2 Diabetic Kidney Disease.
Kwon S; Kim YC; Park JY; Lee J; An JN; Kim CT; Oh S; Park S; Kim DK; Oh YK; Kim YS; Lim CS; Lee JP
Diabetes Care; 2020 May; 43(5):948-955. PubMed ID: 32132005
[TBL] [Abstract][Full Text] [Related]
7. Hospitalization for Lactic Acidosis Among Patients With Reduced Kidney Function Treated With Metformin or Sulfonylureas.
Chu PY; Hackstadt AJ; Chipman J; Griffin MR; Hung AM; Greevy RA; Grijalva CG; Elasy T; Roumie CL
Diabetes Care; 2020 Jul; 43(7):1462-1470. PubMed ID: 32327421
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology of lactic acidosis in type 2 diabetes patients with metformin in Japan.
Chang CH; Sakaguchi M; Dolin P
Pharmacoepidemiol Drug Saf; 2016 Oct; 25(10):1196-1203. PubMed ID: 27221971
[TBL] [Abstract][Full Text] [Related]
9. Metformin associated lactic acidosis: incidence and clinical correlation with metformin serum concentration measurements.
van Berlo-van de Laar IR; Vermeij CG; Doorenbos CJ
J Clin Pharm Ther; 2011 Jun; 36(3):376-82. PubMed ID: 21545617
[TBL] [Abstract][Full Text] [Related]
10. Metformin: time to review its role and safety in chronic kidney disease.
Tanner C; Wang G; Liu N; Andrikopoulos S; Zajac JD; Ekinci EI
Med J Aust; 2019 Jul; 211(1):37-42. PubMed ID: 31187887
[TBL] [Abstract][Full Text] [Related]
11. Lactate levels and risk of lactic acidosis with metformin in diabetic kidney disease patients.
Bipi PK; George J; Gomathy S; Gracious N; Kumar S; Mohandas MK
Saudi J Kidney Dis Transpl; 2017; 28(6):1356-1361. PubMed ID: 29265047
[TBL] [Abstract][Full Text] [Related]
12. Lactic acidosis due to metformin in type 2 diabetes mellitus and chronic kidney disease stage 3-5: is it significant?
Prabhu RA; Mareddy AS; Nagaraju SP; Rangaswamy D; Guddattu V
Int Urol Nephrol; 2019 Jul; 51(7):1229-1230. PubMed ID: 30963454
[TBL] [Abstract][Full Text] [Related]
13. Should Restrictions Be Relaxed for Metformin Use in Chronic Kidney Disease? No, We Should Never Again Compromise Safety!
Kalantar-Zadeh K; Kovesdy CP
Diabetes Care; 2016 Jul; 39(7):1281-6. PubMed ID: 27330129
[TBL] [Abstract][Full Text] [Related]
14. Lactic acidosis incidence with metformin in patients with type 2 diabetes and chronic kidney disease: A retrospective nested case-control study.
Alvarez CA; Halm EA; Pugh MJV; McGuire DK; Hennessy S; Miller RT; Lingvay I; Vouri SM; Zullo AR; Yang H; Chansard M; Mortensen EM
Endocrinol Diabetes Metab; 2021 Jan; 4(1):e00170. PubMed ID: 33532612
[TBL] [Abstract][Full Text] [Related]
15. Lactic acidosis associated with metformin in patients with moderate to severe chronic kidney disease: study protocol for a multicenter population-based case-control study using health databases.
Pedrós C; Ávila M; Gómez-Lumbreras A; Manríquez M; Morros R;
BMC Nephrol; 2019 May; 20(1):193. PubMed ID: 31146690
[TBL] [Abstract][Full Text] [Related]
16. Refining metformin prescribing in New Zealand.
Jayathissa S; Dixon P; Bruce R; Reith D
N Z Med J; 2017 Mar; 130(1452):49-53. PubMed ID: 28337040
[TBL] [Abstract][Full Text] [Related]
17. Association between Metformin Use and Risk of Lactic Acidosis or Elevated Lactate Concentration in Type 2 Diabetes.
Lee EY; Hwang S; Lee YH; Lee SH; Lee YM; Kang HP; Han E; Lee W; Lee BW; Kang ES; Cha BS; Lee HC
Yonsei Med J; 2017 Mar; 58(2):312-318. PubMed ID: 28120561
[TBL] [Abstract][Full Text] [Related]
18. Adverse event notifications implicating metformin with lactic acidosis in Australia.
Huang W; Castelino RL; Peterson GM
J Diabetes Complications; 2015; 29(8):1261-5. PubMed ID: 26104729
[TBL] [Abstract][Full Text] [Related]
19. Metformin-associated lactic acidosis: a rare or very rare clinical entity?
Chan NN; Brain HP; Feher MD
Diabet Med; 1999 Apr; 16(4):273-81. PubMed ID: 10220200
[TBL] [Abstract][Full Text] [Related]
20. Should Restrictions Be Relaxed for Metformin Use in Chronic Kidney Disease? Yes, They Should Be Relaxed! What's the Fuss?
Bakris GL; Molitch ME
Diabetes Care; 2016 Jul; 39(7):1287-91. PubMed ID: 27330130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]